Radiosensitivity of human lymphocytes was extensively studied in vitro (Kwan & Norman, 1977; Manori et al., 1984; Prosser, 1976; Szczylik & Wiktor-Jedrzejczak, 1981; Wasserman et al., 1982a, b) and in vivo (Haas et al., 1984; Hoppe et al., 1977; Job et al., 1984; Kotzin et al., 1983; Petrini et al., 1977; Posner et al., 1983; Schulof et al., 1985; Idestrom et al., 1979) . Results are confficting but suggest that B lymphocytes and helper T cells are more radiosensitive than T lymphocytes and cytotoxic/suppressor cells respectively. However, data from in vitro and in vivo experiments are not really convincing. On the one hand in vitro conditions may not accurately reflect in vivo conditions. On the other hand, in the in vivo studies radiation treatment was only given to a part of the hemopoietic and/or lymphoid system. Therefore a redistribution and/or repopulation of lymphocytes from non irradiated areas might have occurred and prevented an accurate evaluation of the radiosensitivity of the peripheral blood lymphocyte subsets. Furthermore it has recently been suggested that a possible radioresistant lymphocyte subset might be responsible for the rejection of T cell depleted bone marrow grafts after conditioning treatment with total body irradiation and chemotherapy (Dennert et al., 1985; Hall & Dorsch, 1984) . We therefore decided to undertake our own in vivo study to determine the radiosensitivity of different lymphocyte subsets and try to pinpoint a particular radioresistant subset which could be incriminated in graft rejection. In our institution, hyperfractionated total body irradiation provided us with a unique model for the study of lymphocyte radiosensitivity in vivo. This model is unique in that irradiation was given to the whole lymphoid and bone marrow system thus preventing possible redistribution and/or repopulation from non irradiated areas.
Patients included in the study were leukaemia patients in complete remission and without any therapy for at least a month. Hyperfractionated total body irradiation (HTBI) was delivered in 11 fractions over 4 days, three fractions of 120-135 cGy a day. The first fraction was given on Monday at 6 pm, and the second fraction on Tuesday morning at 7.30 am. The study on lymphocytes took place between those two fractions. Lymphocyte blood counts were determined before radiation treatment in the morning (6 am), and just before the first radiation treatment (6 pm). After the first fraction they were determined 4 and 12 h later. Blood samples for lymphocyte subset analysis were obtained 12 h before and 12 h after the first fraction of TBI (120) (121) (122) (123) (124) (125) (126) (127) (128) (129) (130) (131) (132) (133) (134) (135) In the present investigation because the fraction size was relatively small blood lymphocyte numbers were high enough to allow an adequate study of the decline in the different lymphocyte subsets. The size of the fraction also seemed to be appropriate for the studies of lymphocyte radiosensitivity, because cell or tissue radiosensitivity is better defined by its surviving fraction at 2 Gy (Fertil & Malaise, 1981; Deacon et al., 1984) . From March 1988 to July 1989, 20 patients were entered into the study. The mean age was 18.8 ± 8.5. Eleven patients were diagnosed as having ALL, five patients had ANLL, one patient had CML, and three had lymphoblastic lymphoma. All patients were in complete remission and off therapy for at least 1 month.
The decrease in peripheral blood lymphocytes during a hyperfractionated TBI has already been described by Shank et al. (1983) . In our study we focused on early cell kinetics after the first fraction of a hyperfractionated TBI. Total lymphocyte counts decreased to approximately 65% (64 + 17%) of the pretreatment counts (morning values preceding the first radiation treatment). Interestingly a sharp drop occurred in the first 4 h (75% of the total decrease) with a further but slow decline in the following 8 h (Figure 1 ). This finding suggested that at least 4 to 12 h are required after radiation treatment to adequately assess the decline in lymphocytes. An overestimation in lymphocyte survival might occur if such an interval is not respected. It is noteworthy to underline that the substantial drop in the first 4 h in vivo does not occur in vitro which is only observed after 2 to 3 days (Prosser, 1976; Szczylik & Wiktor-Jedrzejczak, 1981; Wasserman et al., 1982b; Dutreix et al., 1987) . These different kinetics between in vivo and in vitro experiments seem to suggest a rapid removal of doomed lymphocytes in vivo by a yet unknown mechanism. In our study all lymphocyte subsets appeared to be equally sensitive to the in vivo radiation (Table I ). These findings contradict many previous in vivo studies (Job et al., 1984; Kotzin et al., 1983; Petrini et al., 1977; Posner et al., 1983; Schulof et al., 1985; Toivanen et al., 1984; Idestrom et al., 1979) . This discrepancy could be explained by two facts. Firstly, in earlier studies irradiation was given to a part of the hemopoietic and lymphoid system; therefore lymphocyte redistribution from non irradiated areas might have occurred, especially from bone marrow where the majority of lymphocytes are CD8 with lesser numbers of CD4 (Janossy et al., 1980 (Janossy et al., , 1987 . This phenomenon might have lead to a larger increase in CD8 cells suggesting CD8 radioresistance. Secondly, in earlier studies (Wasserman et al., 1982a; Hoppe et al., 1977; Job et al., 1984; Schulof et al., 1985; Onsrud et al., 1982) lymphocyte subsets were analysed 2 to 16 weeks after the beginning of the radiation treatment. This period of time might have allowed more rapid CD8 repopulation as already shown in multiple studies (Haas et al., 1984; Kotzin et al., 1983; Posner et al., 1983 ; our unpublished data) and therefore lead to a false impression of CD8 radioresistance. An additional factor could explain the different results between our study and other in vivo studies. In our study the TBI dose yielded a decrease in lymphocyte numbers which might have been too small to detect any difference in radiosensitivity among the lymphocyte subsets. The study of the lymphocyte subsets during and at the end of the total body irradiation might have provided additional information on their radiosensitivity, but was not feasible for practical and ethical reasons.
In conclusion, this study showed that the disappearance of peripheral blood lymphocytes occurred 4 to 12 h after the first fraction of TBI and that the different lymphocyte subsets (T and B lymphocytes, helper and cytotoxic/suppressor T lymphocytes, natural killer cells) exhibited equal radiosensitivity.
